Physiomics Plc (LON:PYC – Get Free Report) rose 8.6% during trading on Wednesday . The stock traded as high as GBX 0.55 and last traded at GBX 0.52. 20,602,037 shares traded hands during trading, an increase of 241% from the average session volume of 6,044,670 shares. The stock had previously closed at GBX 0.47.
Physiomics Stock Performance
The stock has a 50 day moving average of GBX 0.49 and a two-hundred day moving average of GBX 0.50. The stock has a market cap of £2.34 million, a PE ratio of -3.44 and a beta of 1.05.
Physiomics Company Profile
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union Switzerland. The company offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. It also develops technology for use in the field of personalized medicine. The company was incorporated in 2001 and is based in Oxford, the United Kingdom.
See Also
- Five stocks we like better than Physiomics
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
- Gold Defied the Fed’s Rate Hike—These 3 Plays Stand Out
Receive News & Ratings for Physiomics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Physiomics and related companies with MarketBeat.com's FREE daily email newsletter.
